AN2 Therapeutics Inc
NASDAQ:ANTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AN2 Therapeutics Inc
NASDAQ:ANTX
|
US |
|
Lucapa Diamond Co Ltd
ASX:LOM
|
AU |
|
Brioschi Sviluppo Immobiliare SpA
MIL:BRI
|
IT |
|
Kiplin Metals Inc
XTSX:KIP
|
CA |
|
colorTV Ltd
ASX:CTV
|
AU |
|
Warner Bros Discovery Inc
NASDAQ:WBD
|
US |
|
Samaraenergo PAO
MOEX:SAGO
|
RU |
|
JCHX Mining Management Co Ltd
SSE:603979
|
CN |
|
Finsbury Food Group PLC
LSE:FIF
|
UK |
|
SBC Medical Group Holdings Inc
NASDAQ:SBC
|
US |
|
P
|
Psyence Group Inc
CNSX:PSYG
|
CA |
Wall Street
Price Targets
ANTX Price Targets Summary
AN2 Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
ANTX
is 1.02 USD
with a low forecast of 1.01 USD and a high forecast of 1.05 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ANTX's stock price target?
Price Target
1.02
USD
According to Wall Street analysts, the average 1-year price target for
ANTX
is 1.02 USD
with a low forecast of 1.01 USD and a high forecast of 1.05 USD.